We are live on ! Find out more
N

Nuveen Portfolio holdings

AUM $369B
1-Year Est. Return 31.66%
This Fund
S&P 500
This Quarter Est. Return
+7.89%
1 Year Est. Return
+31.66%
3 Year Est. Return
+110.02%
5 Year Est. Return
+148.02%
10 Year Est. Return
+492.84%
AUM
$314B
AUM Growth
+$19.1B
Cap. Flow
+$92.3M
Cap. Flow %
0.03%
Top 10 Hldgs %
20.84%
Holding
3,440
New
118
Increased
1,247
Reduced
1,874
Closed
82

Top Sells

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$1.37B
2
DD icon
DuPont de Nemours
DD
+$556M
3
QCOM icon
Qualcomm
QCOM
+$405M
4
MRK icon
Merck
MRK
+$333M
5
TSM icon
TSMC
TSM
+$315M

Sector Composition

Rank Sector Weight
1 Technology 23.31%
2 Consumer Discretionary 12.98%
3 Financials 12.81%
4 Healthcare 12.54%
5 Communication Services 9.93%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
NTCT icon
1826
NETSCOUT
NTCT
$2.79B
$9.2M ﹤0.01%
326,515
+122
+0% +$3.58K
CNDT icon
1827
Conduent
CNDT
$264M
$9.19M ﹤0.01%
1,380,449
-656,097
-32% -$3.74M
SPCE icon
1828
Virgin Galactic
SPCE
$398M
$9.19M ﹤0.01%
15,008
-433
-3% -$326K
BDC icon
1829
Belden
BDC
$5.19B
$9.12M ﹤0.01%
205,552
-62,448
-23% -$2.84M
SRNE
1830
DELISTED
Sorrento Therapeutics, Inc.
SRNE
$9.12M ﹤0.01%
1,102,463
-173,671
-14% -$1.83M
AHRT
1831
AH Realty Trust
AHRT
$517M
$9.11M ﹤0.01%
726,689
-47,318
-6% -$579K
SVC
1832
Service Properties Trust
SVC
$1.07B
$9.1M ﹤0.01%
153,394
-2,581
-2% -$155K
CRS icon
1833
Carpenter Technology
CRS
$28.4B
$9.1M ﹤0.01%
221,015
-2,985
-1% -$113K
APEI icon
1834
American Public Education
APEI
$940M
$9.07M ﹤0.01%
254,475
-20,777
-8% -$650K
SASR
1835
DELISTED
Sandy Spring Bancorp Inc
SASR
$9.05M ﹤0.01%
208,413
-3,024
-1% -$115K
PACK icon
1836
Ranpak Holdings
PACK
$473M
$9.02M ﹤0.01%
449,495
+222,500
+98% +$4.14M
MD icon
1837
Pediatrix Medical
MD
$2.2B
$9M ﹤0.01%
353,212
-3,737
-1% -$95.7K
VNET
1838
VNET Group
VNET
$2.09B
$8.99M ﹤0.01%
278,500
+202,560
+267% +$7.46M
PKX icon
1839
POSCO
PKX
$17.5B
$8.96M ﹤0.01%
124,125
-9,067
-7% -$578K
TBIO
1840
DELISTED
Translate Bio, Inc. Common Stock
TBIO
$8.95M ﹤0.01%
542,649
-2,286
-0.4% -$52.1K
OMER icon
1841
Omeros
OMER
$959M
$8.93M ﹤0.01%
501,559
-62,747
-11% -$1.22M
SBCF icon
1842
Seacoast Banking Corp of Florida
SBCF
$3.35B
$8.93M ﹤0.01%
246,299
-4,669
-2% -$163K
ROAD icon
1843
Construction Partners
ROAD
$6.77B
$8.88M ﹤0.01%
297,170
-10,329
-3% -$312K
PAHC icon
1844
Phibro Animal Health
PAHC
$1.39B
$8.86M ﹤0.01%
362,931
+14,219
+4% +$321K
HLF icon
1845
Herbalife
HLF
$1.29B
$8.84M ﹤0.01%
199,163
-297,885
-60% -$14.7M
PMT
1846
PennyMac Mortgage Investment
PMT
$842M
$8.82M ﹤0.01%
449,791
-4,716
-1% -$87.4K
EHTH icon
1847
eHealth
EHTH
$43.9M
$8.8M ﹤0.01%
120,958
+1,698
+1% +$109K
FLEX icon
1848
Flex
FLEX
$44.8B
$8.79M ﹤0.01%
637,286
-1,068,052
-63% -$14.7M
FARO
1849
DELISTED
Faro Technologies
FARO
$8.78M ﹤0.01%
101,419
+7,939
+8% +$658K
STRO icon
1850
Sutro Biopharma
STRO
$421M
$8.77M ﹤0.01%
38,523
+12,091
+46% +$2.87M

Similar funds

Nuveen's Q1 2021 Portfolio in Review

As of Q1 2021, Nuveen held 3,440 positions worth $314B, up 6.5% from $295B the previous quarter. Its ten largest holdings account for 21% of the portfolio.

Nuveen's Q1 2021 filing shows 118 new, 1,247 increased, 1,874 reduced and 82 closed positions. Its largest new stake was Coupang: 6,313,287 shares worth $312M. The largest sale was Apple, an estimated $1.37B.

By sector, the portfolio is most concentrated in Technology at 23% of assets, down from 25% a quarter earlier, followed by Consumer Discretionary and Financials.

  • Nuveen's largest Q1 2021 buy was Coupang: 6,313,287 shares worth $312M.
  • Nuveen added most to Intel in Q1 2021, an estimated $905M increase.
  • Nuveen's biggest Q1 2021 reduction was Apple, cutting an estimated $1.37B.
  • Nuveen fully exited PARSLEY ENERGY INC in Q1 2021, selling an estimated $122M.
  • Nuveen's ten largest holdings make up 21% of its $314B portfolio in Q1 2021.
  • Nuveen opened 118 new positions and closed 82 in Q1 2021.
  • Nuveen's portfolio value rose 6.5% quarter-over-quarter to $314B.

Based on Nuveen's 13F filing for Q1 2021, filed 17 May 2021.